ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 90 • 2016 ACR/ARHP Annual Meeting

    Impacts of Anti-TNF Treatment on Improvement in Work Place and Household Productivity in Patients with Psoriatic Arthritis

    Omer Karadag1, Ediz Dalkilic2, Ahmet Mesut Onat3, Orhan Kucuksahin4, Timucin Kasifoglu5, Bunyamin Kisacik6, Omer Nuri Pamuk7, Neslihan Yilmaz8, Suleyman Serdar Koca9, Veli Yazisiz10, Pinar Talu Ocakci11, Mehmet Sayarlioglu12, Ender Terzioglu13, Sukran Erten14,15, Mustafa Ferhat Oksuz16 and Umut Kalyoncu1, 1Rheumatology, Hacettepe University Faculty of Medicine, Ankara, Turkey, 2Department of Rhematology, Uludag University Faculty of Medicine, Bursa, Turkey, 3Department Of Internal Medicine, Division of Rheumatology, Gaziantep University, Gaziantep University,Division of Rheumatology, Gaziantep, Turkey, 4Rheumatology, Yildirim Beyazit University Faculty of Medicine, Ankara, Turkey, 5Rheumatology, Eskisehir Osmangazi University Faculty of Medicine, Eskişehir, Turkey, 6Rheumatology Department, Gaziantep University School of Medicine, Gaziantep, Turkey, 7Rheumatology, Trakya University Faculty of Medicine, Edirne, Turkey, 8Department of Rheumatology, Bilim University Faculty of Medicine, Istanbul, Turkey, 9Department of Rheumatology Faculty of Medicine Firat University, Elazig, Turkey, 10Rheumatology, Akdeniz University Faculty of Medicine, Antalya, Turkey, 11Rheumatology, İzmir University Faculty of Medicine, izmir, Turkey, 12Rheumatology, Ondokuz Mayis University Faculty of Medicine, Samsun, Turkey, 13Division of Rheumatology, Akdeniz University Faculty of Medicine, Antalya, Turkey, 14Rheumatology, Ataturk Training and Research Hospital, Ankara, Turkey, 15Rheumatology, Yildirim Beyazit University Faculty Of Medicine, Ankara, Turkey, 16Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkey

    Background/Purpose: Psoriatic arthritis (PsA) is a unique inflammatory arthritis that affects the skin, nails, and the joints. Most of the patients consider PsA to have…
  • Abstract Number: 91 • 2016 ACR/ARHP Annual Meeting

    A Systematic Review of Smartphone Applications for Measuring and Recording Rheumatoid Arthritis Disease Activity

    Rebecca Grainger1,2, Hermaleigh Townsley3, Bonnie White4, Tobias Langlotz5 and William Taylor1,6, 1University of Otago Wellington, Wellington, New Zealand, 2Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Lower Hutt, New Zealand, 3Department of Medicine, University of Otago Wellington, Wellington, New Zealand, 4Department of Medicine, University of Otago Wellington, Wellington South, New Zealand, 5Department of Information Science, University of Otago, Dunedin, New Zealand, 6Wellington Regional Rheumatology Unit, Hutt Valley District Health Board, Wellington, New Zealand

    Background/Purpose: It is recommended that management of rheumatoid arthritis (RA) requires regular quantitative assessment of RA activity. Treat to target management could be facilitated by use…
  • Abstract Number: 92 • 2016 ACR/ARHP Annual Meeting

    Is Patient Support Program (PSP) Participation Associated with Longer Persistence and Greater Adherence Among New Users of Adalimumab?

    Einav Srulovici1,2, Vishvas Garg3, Adi Ghilai2, Becca Feldman2, Moshe Hoshen2, Ran Balicer2, Martha Skup4 and Maya Leventer-Roberts2, 1School of Nursing, University of Haifa, Haifa, Israel, 2Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel, 3AbbVie Inc, North Chicago, IL, 4AbbVie Inc., North Chicago, IL

    Background/Purpose: In Israel, patients treated with adalimumab (ADA) can enroll in a patient support program (PSP) provided by AbbVie, which includes a home visit by…
  • Abstract Number: 93 • 2016 ACR/ARHP Annual Meeting

    2015 ACR/ARHP Workforce Study in the United States: Adult Rheumatologist Supply and Demand Projections for 2015-2030

    Daniel Battafarano1, Seetha Monrad2, John Fitzgerald3, Marcy Bolster4, Chad Deal5,6, Anne R. Bass7, Rodolfo Molina8, Alan R. Erickson9, Benjamin J Smith10, Karla B. Jones11, Jonathan S. Hausmann12, Val Gokenbach13, Kamilah Lewis14 and Marcia Ditmyer15, 1Medicine, San Antonio Military Medical Center, San Antonio, TX, 2Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, 3Medicine, UCLA, Los Angeles, CT, 4Rheumatology, Allergy and Immunology, Massachusetts General Hospital, Boston, MA, 5Orthopedic and Rheumatology Institute, Cleveland Clinic Foundation, Cleaveland, OH, 6Dept of Rheum & Imm Dis /A 50, Cleveland Clinic Foundation, Cleveland, OH, 7Rheumatology, Hospital for Special Surgery, New York, NY, 8Arthritis Associates PA, San Antonio, TX, 9Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 10Rheumatology, McIntosh Clinic, P.C., Thomasville, GA, 11Rheumatology, Nationwide Children's, Columbus, OH, 12Rheumatology, Beth Israel Deaconess Medical Center, Boston, MA, 13Academy for Academic Leadership, Detroit, MI, 14American College of Rheumatology, Atlanta, GA, 15Academy for Academic Research, Las Vegas, NV

    Background/Purpose:   The 2015 ACR Workforce study updated the current and projected adult rheumatology workforce for the next 15 years. Methods: The 2015 ACR/ARHP Workforce…
  • Abstract Number: 94 • 2016 ACR/ARHP Annual Meeting

    Performance of the Patient Reported Outcomes Measurement Information System (PROMIS) Measure for Physical Function in Early RA

    Till Uhlig, Inge C Olsen, Anna-Birgitte Aga, Siri Lillegraven, Tore K Kvien and Espen A. Haavardsholm, Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: The Patient Reported Outcomes Measurement Information System (PROMIS) initiative has developed and calibrated item banks for the assessment of physical function and other domains…
  • Abstract Number: 95 • 2016 ACR/ARHP Annual Meeting

    An Analysis of Malpractice Litigation in Rheumatology

    Arpan Prabhu1, Raghav Gupta2, Ranjit Thomas3 and Chester V. Oddis4, 1University of Pittsburgh School of Medicine, Pittsburgh, PA, 2Rutgers New Jersey Medical School, Newark, NJ, 3Tufts University, Medford, MA, 4Rheumatology/Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose:  Medicine is an increasingly more litigious environment, and the probability of a practitioner facing a medical malpractice claim is high. Given the tumultuous liability…
  • Abstract Number: 96 • 2016 ACR/ARHP Annual Meeting

    Transforming Healthcare in Rheumatology: From Inpatient to Outpatient Care without Reductions in Healthcare Quality

    Andreas P Diamantopoulos1,2 and Timothy T Brown1, 1Public Health, University of California, Berkeley, Berkeley, CA, 2Rheumatology, Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway

    Background/Purpose: The implementation of a major program to improve the quality of care in inflammatory arthritides (rheumatoid arthritis-RA, spondyloarthritis- SpA and psoriatic arthritis- PsA) included…
  • Abstract Number: 97 • 2016 ACR/ARHP Annual Meeting

    Effects of DMARD Tapering on Treatment Costs and Work Productivity in Rheumatoid Arthritis Patients- an Analysis from the Prospective Randomized Controlled Retro- Study

    Melanie Hagen1, Camille P Figueiredo2, Jayme Fogagnolo Cobra3, Judith Haschka4, Michaela Reiser5, Matthias Englbrecht6, Axel J. Hueber7, Bernhard Manger6, Arnd Kleyer8, Stephanie Finzel9, Hans-Peter Tony10, Stefan Kleinert11, Joerg Wendler12, Florian Schuch12, Monika Ronneberger12, Martin Feuchtenberger13, Martin Fleck14, Karin Manger15, Wolfgang Ochs16, Matthias Schmitt-Haendle17, H.-M. Lorenz18, HG Nüßlein19, R Alten20, Joerg C. Henes21, Klaus Krüger22, Georg Schett7 and Juergen Rech7, 1Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nuremberg (FAU), Erlangen, Germany, 2Rheumatology Division, Faculdade de Medicina da USP, São Paulo, Brazil, 3Instituto de Reumatologia de Sao Paolo, Sao Paolo, Brazil, 4Medical Department II, St. Vincent Hospital, the VINFORCE Study Group, Academic Teaching Hospital of Medical University of Vienna, Vienna, Austria, Vienna, Austria, 5Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany, 6Department of Internal Medicine 3, Rheumatology & Clinical Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, 7Department of Internal Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, 8Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, 9Rheumatology and Clinical Immunology, University Medical Center Freiburg, Freiburg, Freiburg, Germany, 10Rheumatology/Immunology, Medical Clinic II, University Clinic Wuerzburg, Würzburg, Germany, 11Rheumatologische Schwerpunktpraxis Erlangen, Erlangen, Germany, 12Schwerpunktpraxis Rheumatologie, Erlangen, Germany, 13Rheumatologie/Klinische Immunologie, Kreiskliniken Altötting-Burghausen, Burghausen, Germany, 14Department of Internal Medicine I, University of Regensburg, 93042 Regensburg, Germany, 15Rheumatology Practice Bamberg, Bamberg, Germany, 16Internistisch-rheumatologische Praxisgemeinschaft Bayreuth, Bayreuth, Germany, 17Rheumatology Practice, Bayreuth, Germany, Bayreuth, Germany, 18Im Neuenheimer Feld 41, UNI-Klinikum Heidelberg, Medizinische Klinik,, Heidelberg, Germany, 19University of Erlangen, Nürnberg, Germany, 20Rheumazentrum Ruhrgebiet, Herne, Germany, 21Department of Internal Medicine II, Division of Rheumatology, University Hospital Tuebingen, Tuebingen, Germany, 22Praxiszentrum St. Bonifatius, München, Germany

    Effects of DMARD Tapering on Treatment Costs and Work Productivity in Rheumatoid Arthritis Patients- an Analysis from the Prospective Randomized Controlled RETRO- Study Background/Purpose: Achieving remission…
  • Abstract Number: 98 • 2016 ACR/ARHP Annual Meeting

    Daily Symptom Reports in a Smartphone-Based Study ‘Cloudy with a Chance of Pain’: Patterns of Attrition over the First Six Months

    Katie Druce1, Sabine N van der Veer2, Mohammed A Chowdhury1, John McBeth3, Jamie C Sergeant1, Rikesh Patel3 and William G Dixon4, 1Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, 2Health e-Research Centre, University of Manchester, Manchester, United Kingdom, 3Manchester Academic Health Science Centre, Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, United Kingdom, 4Arthritis Research UK Centre for Epidemiology, The University of Manchester, Manchester, Great Britain

    Background/Purpose: The increasing uptake of smartphones and health apps provides opportunities for epidemiological studies to collect regular information from large numbers of people. This offers…
  • Abstract Number: 99 • 2016 ACR/ARHP Annual Meeting

    Academic and Non-Academic Rheumatology: Practice Trends and Common Barriers to Practice from the 2015 ACR/ARHP Workforce Study Survey

    Seetha Monrad1, Daniel Battafarano2 and Marcia Ditmyer3, 1Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, 2Medicine, San Antonio Military Medical Center, San Antonio, TX, 3Academy for Academic Research, Las Vegas, NV

    Background/Purpose: Ten years have elapsed since the last ACR workforce study (WFS), and it is anticipated that rheumatologists will face many challenges to train and…
  • Abstract Number: 100 • 2016 ACR/ARHP Annual Meeting

    Patient Support Program for Adalimumab-Treated Patients in Brazil: Impact on Patients’ Adherence and Persistence

    Roger A. Levy1, Vanessa Teich2, Roberta Fernandes2, Anna Gulart2, Leonardo Chaves3, Vishvas Garg4 and Martha Skup5, 1Rheumatology, Department of Rheumatology, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 2Sense Company, São Paulo, Brazil, 3AbbVie Inc., Chicago, IL, 4AbbVie Inc, North Chicago, IL, 5AbbVie Inc., North Chicago, IL

    Background/Purpose: The Brazilian public healthcare system covers treatment with adalimumab for rheumatoid arthritis, Crohn's disease, ankylosing spondylitis and psoriatic arthritis, in line with local guidelines.…
  • Abstract Number: 101 • 2016 ACR/ARHP Annual Meeting

    Rheumatology Care Utilization and Geographic Distance from Rheumatology Sites within the United States Veteran Affairs Health Care System

    Jessica A. Walsh1, Zachary Burningham2, Chia-Chen Teng, MS3, Daniel O. Clegg4 and Brian C. Sauer, PhD3, 1University of Utah School of Medicine, Salt Lake City, UT, 2SLC Veterans Affairs Medical Center, SLC IDEAS Center, Salt Lake City, UT, 3Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 4Division of Rheumatology, University of Utah Medical Center, Salt Lake City, UT

    Background/Purpose: Within the Veteran Affairs (VA) health care system, there are often large geographic distances between patients and rheumatology providers. The purpose of this study…
  • Abstract Number: 102 • 2016 ACR/ARHP Annual Meeting

    The 2015 American College of Rheumatology (ACR) Workforce Study: A Snapshot of Academic Division Directors

    Marisa S. Klein-Gitelman1, Daniel Battafarano2, Seetha Monrad3 and Marcia Ditmyer4, 1Div of Pediatric Rheumatology/PDD PTD, Lurie Children's Hospital of Chicago/NW University, Chicago, IL, 2Medicine, San Antonio Military Medical Center, San Antonio, TX, 3Internal Medicine/Rheumatology, University of Michigan, Ann Arbor, MI, 4Academy for Academic Research, Las Vegas, NV

    Background/Purpose: The ACR has engaged in workforce studies as a mechanism to address ongoing and future needs of college members.  In order to address needs…
  • Abstract Number: 103 • 2016 ACR/ARHP Annual Meeting

    People with Rheumatoid Arthritis Recruited from an Online Patient Community May Differ from Clinical Populations in Symptoms and Impacts

    Anna Kristina Gutierrez1, Susan J. Bartlett1,2, Michelle Jones3, W. Benjamin Nowell4, Seth D. Ginsberg4, Vivian P. Bykerk5, Jeffrey R. Curtis6 and Clifton Bingham III7, 1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Department of Medicine, Division of ClinEpi, Rheumatology, Respirology, McGill University, Montreal, QC, Canada, 3Johns Hopkins University School of Medicine, Baltimore, MD, 4Global Healthy Living Foundation, CreakyJoints, Upper Nyack, NY, 5Divison of Rheumatology, Hospital for Special Surgery, New York, NY, 6Division Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 7Johns Hopkins University, Baltimore, MD

    Background/Purpose: Patients are increasingly recruited from online communities to provide insight regarding their lived experiences and preferences for treatment and services. We compared physical, social,…
  • Abstract Number: 104 • 2016 ACR/ARHP Annual Meeting

    Incremental Direct Expenditures Due to Osteoarthritis: A Nationally Representative Study Using Medical Expenditure Panel Survey Data

    Jyothi Menon, Purdue University, West Lafayette, IN

    Background/Purpose:  Osteoarthritis is characterized by symptoms related to abnormalities in joints, subchondral bones and periarticular structures. In the United States, it was estimated that twenty-seven…
  • « Previous Page
  • 1
  • …
  • 1422
  • 1423
  • 1424
  • 1425
  • 1426
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology